International Stem Cell Co. (OTCMKTS:ISCO) Sees Large Increase in Short Interest

International Stem Cell Co. (OTCMKTS:ISCO) was the recipient of a significant increase in short interest in the month of December. As of December 31st, there was short interest totalling 1,500 shares, an increase of 400.0% from the December 15th total of 300 shares. Based on an average daily trading volume, of 22,400 shares, the days-to-cover ratio is currently 0.1 days.

International Stem Cell Stock Performance

Shares of ISCO remained flat at $0.10 during mid-day trading on Wednesday. 39 shares of the stock were exchanged, compared to its average volume of 4,939. International Stem Cell has a 12-month low of $0.05 and a 12-month high of $0.20. The firm has a market cap of $800,000.00, a P/E ratio of -1.25 and a beta of 0.21. The business has a 50-day simple moving average of $0.09 and a two-hundred day simple moving average of $0.08.

About International Stem Cell

International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally. It develops ISC- hpNSC, a neural stem cell program that has completed the Phase I clinical trial for the treatment of Parkinson's disease, as well as for treating stroke and traumatic brain injury.